Retinal pigment epithelial dystrophy (RPED) is a hereditary degenerative eye disease affecting the retinal pigment epithelium (RPE) cells in dogs. This rare form of progressive retinal atrophy (PRA) primarily impacts the pigment cells at the centre of the retina, leading to gradual vision impairment while often sparing peripheral vision. Although RPED tends to develop in older dogs, it causes less severe vision loss compared to other retinal conditions and rarely results in complete blindness.
Dogs suffering from RPED typically have difficulty focusing on stationary objects, especially in bright natural or artificial light. Their central vision is impaired due to damage in the retinal pigment cells, but their peripheral vision usually remains intact. Affected dogs may see moving objects more clearly, though as the disease progresses, their overall vision worsens. This can pose challenges particularly for working dogs exposed to bright light, although total blindness is uncommon.
A full medical and ophthalmic history is essential for diagnosis. A veterinary surgeon will carefully examine the dog's eyes and rule out other causes of vision impairment, such as chronic vitamin E deficiency. Referral to a veterinary ophthalmologist may be necessary for advanced diagnostic tests. Clinical evaluations can be supplemented with genetic testing, such as DNA screening for the RPED gene mutation, and assessments via the Canine Eye Registry Foundation (CERF) to confirm diagnosis and inform breeding decisions.
Certain breeds have a higher risk of inheriting RPED, with most diagnoses occurring in dogs aged 18 months or older. Collie breeds, including Rough Collie puppies and Smooth Collie puppies, are particularly prone. Other breeds at risk include the Briard puppies, Golden Retriever puppies, Labrador Retriever puppies, Shetland Sheepdog, English Cocker Spaniel, English Springer Spaniel, and Cardigan Welsh Corgi. Responsible breeders should ensure eye testing of all breeding stock to reduce the incidence of RPED.
Currently, there is no cure or specific treatment for RPED. Management focuses on regular monitoring and supportive care. Supplementation with vitamin E may be recommended as it has shown some potential benefits in certain affected breeds, although evidence of its effectiveness remains inconclusive. It is crucial to prevent breeding affected dogs, so they should be neutered or spayed to avoid passing the condition to offspring. Early eye screening for predisposed breeds helps reduce RPED prevalence through informed breeding practices.
While RPED impairs central vision, most dogs maintain sufficient peripheral sight and quality of life. Affected dogs can often adapt well, continuing to enjoy a full and happy life despite vision challenges. Owners should provide a stable environment and avoid sudden changes that may disorient their pets. Regular veterinary check-ups and consultation with ophthalmology specialists will help in managing any progression and maintaining the dog's wellbeing.
In summary, RPED is a progressive but generally manageable inherited retinal disorder. Through responsible breeding, early diagnosis, and attentive care, affected dogs can lead fulfilling lives without complete loss of vision.